Source link : https://www.newshealth.biz/health-news/should-chemo-free-regimen-become-new-standard/
MADRID — The chemotherapy-free combination of all-trans retinoic acid (ATRA) and arsenic trioxide (ATO) that is standard in treating low-risk acute promyelocytic leukemia (APL) also shows superior benefits in the high-risk APL population, suggesting the regimen should become the standard in those patients as well, new research shows. “First-line therapy with ATRA-ATO with two initial […]
Author : News Health
Publish date : 2024-06-21 12:25:15
Copyright for syndicated content belongs to the linked Source.
Categories